[Clinical efficacy of burning mouth syndrome treated by livial].
OBJECTIVE
To observe the clinical efficacy of livial on postmenopause women with burning mouth syndrome.


METHODS
Fifty six postmenopause women with burning mouth syndrome were randomly divided into two groups, 26 patients were treated with livial as the treatment group, 30 patients were treated with oryzanol and vitamin E as the control. To evaluate the effect, all the patients were observed in 3-6 months after therapy.


RESULTS
The result showed that the total effective rate of the treatment group was 84.62% after 3 months, 88.46% after 6 months, and significantly higher than that in the control(P < 0.005).


CONCLUSIONS
It is indicated that livial is safer and more effective than nylestriol in treatment with burning mouth syndrome.
Peng
J Y
JY
Department of Stomatology, Xiangya Hospital, Central South University, Changsha 410008, China.
Wu
Y F
YF
Han
W N
WN
D000328:Adult; D002054:Burning Mouth Syndrome / Q000188:drug therapy*; D020847:Estrogen Receptor Modulators / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009652:Norpregnenes / Q000627:therapeutic use*; D017698:Postmenopause
D020847:Estrogen Receptor Modulators; D009652:Norpregnenes; C027385:tibolone